Pancreatic Polypeptide Tumor
📧 Sign up to get email alerts when something new happens for Pancreatic Polypeptide Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of everolimus and vatalanib in patients with advanced solid tumors, including several neuroendocrin…
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating temozolomide with or without capecitabine in advanced pancreatic neuroendocrine tumors, including subtypes such as …
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating regorafenib in advanced or metastatic neuroendocrine tumors has been completed with posted results.
-
CLINICAL_TRIALS withdrawal · 2017-07-19Clinical Trial Update: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of dovitinib lactate for pancreatic neuroendocrine tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer [Phase 2]
Phase 2 trial investigating pazopanib hydrochloride in advanced neuroendocrine tumors; results completed and posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with progressive metastatic neuroendocrine tumors has completed; results were posted…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial update evaluating gefitinib in patients with progressive/metastatic neuroendocrine tumors has completed. The study en…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of romidepsin for locally advanced or metastatic neuroendocrine tumors was terminated; the document lists the conditions studi…